Genetic causes of lichen sclerosus
Part of Skin clinical trials.
This study looks for genetic changes that may increase the risk of developing lichen sclerosus, a chronic skin condition. If you or a close family member have been diagnosed, your participation could help researchers understand why some people get this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with lichen sclerosus (based on a skin exam or biopsy).
- You are a family member of someone with lichen sclerosus.
- You do not need to have a family member with lichen sclerosus if you personally have the condition.
- If you have lichen sclerosus, we will also ask about your family members who may have it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a laser treatment for women with vulvar lichen sclerosus to see if it can help with symptoms like itching, burning, pain, or soreness. It's a option for those who have had a biopsy to confirm the condition.
This study looks at people with lichen planus (a rash that can affect skin, mouth, or genitals) to find markers in cells and blood that may help understand the disease. If you have a new diagnosis or a flare-up, and you are not on strong immune-suppressing medicine, you may be able to join.
This study looks at families where two first-degree relatives have systemic scleroderma, a rare autoimmune disease that affects the skin and organs. It aims to understand genetic and environmental factors by examining patients and their family members.
This study looks at what causes lichen sclerosus in men, how different treatments work, and how the condition affects daily life. If you have lichen sclerosus or are a man without it, you might help researchers learn more.
This trial tests a cream called delgocitinib for adults with lichen sclerosus in the genital area. It aims to see if the cream can safely and effectively reduce symptoms over 52 weeks.
This trial compares three treatments for vulvar lichen sclerosus: a steroid ointment, a non-steroid ointment, and platelet-rich plasma therapy. It aims to see which works best for managing symptoms and improving skin health.
Hear when a new Lichen Sclerosus Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.